PatternsRadar
Sign in

TORNTPHARMTorrent Pharmaceuticals Limited

NSEF&O
4,689.50INR+78.50 (+1.70%)Close · 20 Nov 2026
23 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1.78L CrMarket cap
84.0P/E (TTM)
61.1%Delivery

Filings & corporate actions

82 results filed
CSV
Next results · Q3 FY27
Expected 24 Jan 2027 – 13 Feb 2027
Estimate: filed 24–44 days after quarter end, last 5 times
Dividend
₹9.00 per share · last 29 May 2026
2026
  • 23 OctresultsResults · Q2 FY27 · consolidated and standalone+0.6%NSE
  • 15 OctshareholdingShareholding · 30 Sept 2026+0.1%NSE
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone+5.1%NSE
  • 20 JulshareholdingShareholding · 20 Jul 2026+5.1%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026+5.1%NSE
  • 29 MaydividendDividend · ₹9.00 per share-2.8%
  • 23 MayresultsResults · Q4 FY26 · standalone+1.9%NSE
  • 22 MayresultsResults · Q4 FY26 · consolidated+1.9%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+0.6%NSE
  • 18 FebdividendDividend · ₹29.00 per share-1.1%
  • 13 FebresultsResults · Q3 FY26 · consolidated and standalone+4.5%NSE
  • 3 JanshareholdingShareholding · 31 Dec 2025-0.4%NSE

Reaction to results · all yearsrose on day 0 in 42 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2723 Oct 2026+0.6%+1.6%—2.1×
Q1 FY2730 Jul 2026+5.1%+1.1%+3.7%1.7×
Q4 FY2622 May 2026+1.9%-3.8%+0.6%3.6×
Q3 FY2613 Feb 2026+4.5%+5.6%+5.6%5.4×
Q2 FY267 Nov 2025+6.6%+6.7%+5.0%10.3×
Q1 FY2628 Jul 2025+4.0%-0.9%-1.3%3.1×
Q4 FY2520 May 2025+1.5%-2.3%-0.4%3.4×
Q3 FY2524 Jan 2025+2.8%-1.3%-6.4%6.0×
Q2 FY2525 Oct 2024-3.4%-6.8%-6.1%2.6×
Q1 FY2523 Jul 2024+0.2%+1.1%+7.1%4.1×
Q4 FY2424 May 2024+1.6%+2.5%+8.3%5.6×
Q3 FY242 Feb 2024+4.7%+3.7%+6.6%2.4×
Q2 FY2425 Oct 2023+2.4%+2.3%+12.5%5.2×
Q1 FY247 Aug 2023-0.5%-3.2%-6.3%2.2×
Q4 FY2330 May 2023+7.1%+5.2%+14.0%16.0×
Q3 FY2325 Jan 2023-1.2%-1.6%-4.9%1.5×
Q2 FY2321 Oct 2022-0.4%+7.2%+3.0%0.1×
Q1 FY2329 Jul 2022-0.2%+1.7%+0.4%1.3×
Q4 FY2225 May 2022+10.1%+6.9%+8.4%15.8×
Q3 FY2225 Jan 2022-15.1%-14.4%-15.6%20.8×
Q2 FY2227 Oct 2021-4.2%-4.8%+3.1%3.3×
Q1 FY2227 Jul 2021+2.7%+2.4%+1.7%4.6×
Q4 FY2118 May 2021+1.1%-0.5%+6.1%7.4×
Q3 FY218 Feb 2021-6.4%-6.1%-11.5%6.0×
Q2 FY2126 Oct 2020-2.1%-3.0%-2.7%2.2×
Q1 FY2130 Jul 2020+9.3%+20.7%+11.2%14.7×
Q4 FY2027 May 2020-6.9%-10.6%-4.6%3.4×
Q3 FY2027 Jan 2020-5.5%-4.9%+11.0%6.1×
Q2 FY2023 Oct 2019+5.2%+7.2%+4.8%3.0×
Q1 FY2023 Jul 2019+9.5%+13.8%+13.1%8.9×
Q4 FY1920 May 2019-3.2%-7.9%-9.4%6.2×
Q3 FY1931 Jan 2019-1.1%-1.2%-1.8%0.9×
Q2 FY1919 Nov 2018+0.7%-0.5%+4.1%0.3×
Q1 FY198 Aug 2018-1.1%+2.7%+4.0%1.9×
Q4 FY182 Jul 2018+1.2%+3.2%+6.1%0.4×
Q3 FY1815 Feb 2018+0.2%-5.9%-11.2%2.4×
Q2 FY186 Nov 2017-2.7%-4.1%-1.5%1.4×
Q1 FY1818 Aug 2017-3.1%-5.6%-5.1%0.8×
Q4 FY1718 Jun 2017-0.9%-2.2%+6.9%0.5×
Q3 FY177 Feb 2017+0.2%-1.9%+5.2%2.7×
Q2 FY1722 Dec 2016-2.2%-3.3%-1.5%1.2×
Q1 FY1721 Sept 2016+2.0%+0.4%-0.3%1.4×
Q4 FY1626 May 2016-0.3%0.0%-4.4%1.3×
Q3 FY168 Feb 2016-2.4%-5.3%-4.5%0.9×
Q2 FY1630 Oct 2015-0.3%+0.6%-3.7%1.5×
Q1 FY1629 Jul 2015+1.0%+4.5%+12.9%1.1×
Q4 FY1520 May 20150.0%-0.5%+7.4%0.4×
Q3 FY155 Feb 2015-2.6%+3.8%-1.4%0.6×
Q2 FY1510 Nov 2014+2.1%+7.7%+12.0%0.5×
Q1 FY157 Aug 2014-0.4%+0.6%+15.5%0.8×
Q4 FY1412 May 2014+2.6%-5.7%+3.9%4.0×
Q3 FY1422 Jan 2014+6.7%+0.4%+7.8%6.6×
Q2 FY146 Nov 2013-0.8%-5.6%+1.5%0.4×
Q1 FY141 Aug 2013+2.1%-2.0%-4.9%0.5×
Q4 FY1319 Jun 2013-0.7%-3.5%+6.3%1.5×
Q3 FY1330 Jan 2013-2.2%-6.5%-5.4%2.7×
Q2 FY1329 Oct 2012+0.4%+1.6%-2.2%0.6×
Q1 FY1324 Jul 2012+4.7%+5.5%+7.7%1.4×
Q4 FY1221 May 2012-2.4%+0.2%-4.4%3.0×
Q3 FY1223 Jan 2012-0.5%+3.0%+1.7%0.3×
Q2 FY1219 Oct 2011+1.0%+1.0%-0.4%4.4×
Q1 FY121 Aug 2011-1.5%-4.9%-8.3%1.0×
Q4 FY1130 May 2011+5.8%+1.1%+7.2%11.7×
Q3 FY1119 Jan 2011-5.6%-5.7%-11.1%1.6×
Q2 FY1125 Oct 2010-1.4%-2.0%-1.1%0.2×
Q1 FY1130 Jul 2010-1.8%-1.4%-3.7%2.8×
Q4 FY106 May 2010+0.4%+3.1%+7.9%1.1×
Q3 FY1027 Jan 2010+4.8%+6.8%0.0%2.8×
Q2 FY1031 Oct 2009+2.5%+13.9%+19.0%1.3×
Q1 FY1029 Jul 2009+7.8%+2.1%+28.9%4.3×
Q4 FY0915 May 2009+3.1%+17.6%+19.3%1.4×
Q3 FY0928 Jan 2009-0.3%-4.2%-0.5%0.8×
Q2 FY0924 Oct 2008-7.5%+5.6%-8.1%0.5×
Q1 FY0929 Jul 2008+2.8%+6.2%+18.1%2.6×
Q4 FY086 May 2008-3.2%-6.2%-14.3%8.7×
Q3 FY0831 Jan 2008-0.9%-4.5%-1.3%0.9×
Q2 FY0830 Oct 2007+3.4%+3.0%-0.9%1.9×
Q1 FY0831 Jul 2007+0.5%-3.0%-8.2%1.4×
Q4 FY0723 May 2007+4.5%+29.6%+19.8%5.6×
Average+0.6%+0.7%+2.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+50.8%
Profit YoY-9.6%
Interest cost YoY+308.3%
Revenue QoQ+1.2%
Profit QoQ-5.7%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+24.5%+19.4%—+16.2%+13.9%+11.9%
Profit+8.6%+16.8%—+10.9%+10.0%+21.2%

Key data

Open4,618.90
Day range4,611.20 – 4,689.50
52-week range3,672.30 – 5,250.00
From 52w high-10.7%
RSI (14)50.5
ATR (14)92.66
Volume2.00L
Avg volume (20D)3.22L
Rel volume0.62×
Volatility (1Y)21.5%
Turnover₹93.2Cr
Traded value (NSE)₹93.2Cr
VWAP4,659.46
SMA 50 / 2004,730.52 / 4,564.14
Price bandNo band
MWPL used17.2%

Delivery percentage

Latest · 20 Nov 202661.1%
20-day avg61.6%
1-year avg57.4%
Percentile (own history)68th
Range7.1–99.1%
Sessions3,629

Over the last 20 sessions TORNTPHARM settled 61.6% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 57.4%, so recent sessions are running 4.2 points higher than usual. The latest session ranks higher than 68% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.81%
Dividend, trailing 12M₹38.00
Paid every year for10+ yr
Shareholders1.42L · +1.1% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy2,366 days ago

Performance returns

1D1W1M3M6M1Y
Price+1.70%+0.42%+1.61%-6.30%+4.93%+22.38%

Valuation

Market cap₹1.78L Cr
Market cap (NSE)₹1.78L Cr
Free-float cap₹69,958 Cr
P/E (TTM)84.0
P/E (NSE)83.6
EPS (TTM)55.84
P/B9.7
Net margin (TTM)12.2%
Other income / PBT-1.8%
ROE15.8%
Debt / equity0.76
Shares outstanding38.04Cr
Listed25 Nov 2002

Ownership

Promoter60.78%
Promoter Δ QoQ0.00 pp
Public39.22%
FII17.22%
DII13.46%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)3,303.04,197.04,921.04,979.0
YoY chg+17.6%+41.8%+54.8%+50.8%
Net profit (₹ Cr)635.0364.0566.0534.0
YoY chg+26.2%-26.9%+3.3%-9.6%
Net margin19.2%8.7%11.5%10.7%
EPS18.7711.5114.8714.05

Shareholding over time

By quarter

30 Sept 2026 · promoter 60.78% · public 39.22%
30 Sept 2021: promoter 71.25%31 Dec 2021: promoter 71.25%31 Mar 2022: promoter 71.25%30 Jun 2022: promoter 71.25%13 Jul 2022: promoter 71.25%30 Sept 2022: promoter 71.25%31 Dec 2022: promoter 71.25%31 Mar 2023: promoter 71.25%30 Jun 2023: promoter 71.25%30 Sept 2023: promoter 71.25%31 Dec 2023: promoter 71.25%31 Mar 2024: promoter 71.25%30 Jun 2024: promoter 71.25%30 Sept 2024: promoter 71.25%31 Dec 2024: promoter 68.31%31 Mar 2025: promoter 68.31%30 Jun 2025: promoter 68.31%30 Sept 2025: promoter 68.31%31 Dec 2025: promoter 68.31%31 Mar 2026: promoter 68.31%30 Jun 2026: promoter 68.31%20 Jul 2026: promoter 60.78%30 Sept 2026: promoter 60.78%
2021-092026-09
  • Promoter
  • Public and others
Promoter
60.78%
Public
39.22%
Promoter change
0.00 pp
Filed
15 Oct 2026
FII
17.22%
DII
13.46%
Promoter pledged
0.00%

Who the public is

Mutual funds
8.82%

+0.55 pp QoQ

Insurance
1.96%

-0.07 pp QoQ

FPI
17.22%

-0.75 pp QoQ

Retail ≤ ₹2L
4.55%

+0.12 pp QoQ

HNI > ₹2L
2.40%

+0.01 pp QoQ

NRI
0.22%

0.00 pp QoQ

Bodies corporate
0.36%

+0.02 pp QoQ

Shareholders
1,42,140

+1.1% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
TORRENT INVESTMENTS LIMITED (FORMERLY KNOWN AS TORRENT INVESTMENTS PRIVATE LIMITED)Promoter · Corporate60.78%
NPS TRUSTPension / PF2.32%
HDFC MUTUAL FUNDMutual fund1.14%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUNDMutual fund1.12%
KOTAK DEBT HYBRIDMutual fund1.05%
SUDHIR UTTAMLAL MEHTAPromoter · Individual0.00%
SAMIR UTTAMLAL MEHTAPromoter · Individual0.00%
ANITA SUDHIR MEHTAPromoter · Individual0.00%
SAPNA SAMIR MEHTAPromoter · Individual0.00%
JINAL SUDHIR MEHTAPromoter · Individual0.00%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 27 Jan 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹9.00₹9.00
FY2025-262₹35.00₹35.00
FY2024-252₹32.00₹32.00
FY2023-242₹30.00₹30.00
FY2022-231₹14.00₹14.00
FY2021-222₹40.00₹20.00
FY2020-211₹20.00₹10.00
FY2019-202₹36.00₹18.00
FY2018-192₹18.00₹9.00
FY2017-182₹13.00₹6.50
FY2016-171₹10.00₹5.00
FY2015-163₹41.25₹20.63
FY2014-152₹10.00₹5.00
FY2013-142₹22.00₹6.75
FY2012-132₹8.50₹2.13
FY2011-121₹6.00₹1.50
Ex-dateRecord dateDeclaredAdjusted
29 May 2026—₹9.00₹9.00
18 Feb 2026—₹29.00₹29.00
20 Jun 2025—₹6.00₹6.00
31 Jan 2025—₹26.00₹26.00
21 Jun 2024—₹6.00₹6.00
12 Feb 2024—₹22.00₹22.00
23 Jun 2023—₹8.00₹8.00
3 Feb 2023—₹14.00₹14.00
2 Feb 2022—₹25.00₹12.50
17 Jun 2021—₹15.00₹7.50
15 Feb 2021—₹20.00₹10.00
18 Mar 2020—₹32.00₹16.00
13 Jun 2019—₹4.00₹2.00
6 Feb 2019—₹13.00₹6.50
18 Jun 2018—₹5.00₹2.50
15 Feb 2018—₹9.00₹4.50
19 Jun 2017—₹4.00₹2.00
10 Feb 2017—₹10.00₹5.00
16 Mar 2016—₹15.00₹7.50
11 Feb 2016—₹20.00₹10.00
15 Jun 2015—₹6.25₹3.13
2 Feb 2015—₹5.00₹2.50
16 Jun 2014—₹5.00₹2.50
24 Jan 2014—₹5.00₹2.50
10 Jun 2013—₹17.00₹4.25
1 Feb 2013—₹6.00₹1.50
11 Jun 2012—₹2.50₹0.63
27 Jan 2012—₹6.00₹1.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
31
14 open-market of the newest 31
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
2 Jun 2026Geena MalhotraEmployeeBuy100₹3.9L3,943.84300 → 4000.00%0.00 pp7(2)told 1 Jun 2026
2 Jun 2026Geena MalhotraEmployeeBuy200₹8.0L4,002.99100 → 3000.00%0.00 pp7(2)told 1 Jun 2026
25 Jun 2021Shailesh HaribhaktiDirectorBuy6.9K₹2.0Cr2,899.913.6K → 10.5K0.00%0.00 pp7(2)told 25 Jun 2021
3 Jun 2021Shailesh HaribhaktiDirectorBuy1.1K₹29.4L2,803.832.5K → 3.6K0.00%0.00 pp7(2)told 3 Jun 2021
2 Jun 2021Shailesh HaribhaktiDirectorBuy1.8K₹50.1L2,750.01730 → 2.5K0.00%0.00 pp7(2)told 2 Jun 2021
7 Jan 2021Harish GuttikarOtherSell200₹5.6L2,778.00400 → 2000.00%0.00 pp7(3)told 4 Jan 2021
7 Jan 2021Harish GuttikarOtherBuy400₹10.9L2,716.00— → 4000.00%7(3)told 4 Jan 2021
3 Oct 2020Karan ShahEmployeeSell117₹2.6L2,202.56117 → —0.00%7(2)told 3 Oct 2020
3 Oct 2020Karan ShahEmployeeSell1.1K₹23.1L2,132.091.2K → 1170.00%0.00 pp7(2)told 3 Oct 2020
3 Oct 2020Karan ShahEmployeeBuy117₹2.6L2,201.381.1K → 1.2K0.00%0.00 pp7(2)told 3 Oct 2020
3 Oct 2020Karan ShahEmployeeBuy1.1K₹23.3L2,146.88— → 1.1K0.00%7(2)told 3 Oct 2020
27 Feb 2020Ameera ShahDirectorSell1.2K₹26.6L2,220.001.2K → —0.00%7(2)told 27 Feb 2020
15 Nov 2018Ameera ShahDirectorBuy1.2K₹19.9L1,661.45— → 1.2K0.00%7(2)told 14 Nov 2018
29 Dec 2017Shailesh HaribhaktiDirectorSell6.0K₹83.9L1,398.606.0K → —0.00%7(2)told 29 Dec 2017

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 23 Jan 2025

CSV
12 of 24 deals
By year
DateDealClientQuantityPriceValue
23 Jan 2025Buy · blockUBS AG44.8K3,252.10₹14.6Cr
23 Jan 2025Sell · blockUBS PRINCIPAL CAPITAL ASIA LIMITED44.8K3,252.10₹14.6Cr
7 Mar 2024Buy · blockSEB ASIENFOND EX JAPAN63.3K2,691.20₹17.0Cr
7 Mar 2024Sell · blockSEB FUND 3 SEB PENSION FUND63.3K2,691.20₹17.0Cr
14 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.60L1,669.05₹26.7Cr
14 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.60L1,669.05₹26.7Cr
3 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.60L1,694.30₹27.1Cr
3 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.60L1,694.30₹27.1Cr
3 Oct 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO1.32L1,559.85₹20.6Cr
3 Oct 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF1.32L1,559.85₹20.6Cr
8 Aug 2022Sell · blockISHARES INDIA INDEX MAURITIUS COMPANY1.21L1,556.55₹18.8Cr
8 Aug 2022Buy · blockISHARES MSCI INDIA ETF1.21L1,556.55₹18.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 6 Dec 2024 — P/E above 50 on the last four quarters’ earnings.

Price band: No band · not in the F&O ban · 17.2% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes · MWPL.

Every stock on this session →

Futures & options · 20 Nov 2026

CSV

Long buildup — price up as fresh positions opened — new longs.

Futures OI
39.05L

₹1,831.4Cr

OI change
+1.48%
Basis
-0.62%
Rollover
84.8%
PCR (OI)
0.75
PCR (volume)
1.05
Front settle
4,660.30
Lot size
125

shares

Futures volume
19.6K

contracts

Futures trades
14,100
Futures value
₹1,145.5Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Option chain · 20 Nov 2026 · lot 125

Put OICall OI
Max pain
4,650

-0.8% from spot

Call OI wall
5,000
Put OI wall
4,400
PCR (OI, this expiry)
0.82
PutsStrikeCalls
4,100
4,150
4,200
4,250
4,300
4,350
4,400PW
4,450
4,500
4,550
4,600
4,650MP
Spot 4,689.52
4,700
4,750
4,800
4,850
4,900
4,950
5,000CW
5,050
5,100
5,150
5,200
5,250
5,300

4,650: puts 16.0K OI (−2.5K), close 27.60, ₹10.7Cr notional in 175 trades · calls 13.6K OI (−7.4K), close 38.20, ₹29.5Cr notional in 449 trades

Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations2,732.02,745.02,859.02,889.02,809.02,959.03,178.03,302.03,303.04,197.04,921.04,979.0
Other income(33.0)31.024.0(16.0)33.0(18.0)(37.0)(27.0)(13.0)(17.0)(12.0)(10.0)
Total income2,699.02,776.02,883.02,873.02,842.02,941.03,141.03,275.03,290.04,180.04,909.04,969.0
Total expenses2,156.02,145.02,227.02,212.02,151.02,252.02,403.02,471.02,466.03,585.04,155.04,222.0
└ Finance costs80.080.075.064.057.056.056.048.045.0236.0305.0300.0
└ Depreciation213.0203.0197.0198.0199.0201.0201.0204.0206.0508.0593.0609.0
Profit before tax631.0631.0656.0661.0691.0665.0738.0791.0814.0529.0733.0737.0
Tax expense188.0182.0199.0208.0188.0167.0190.0200.0179.0165.0167.0203.0
Net profit443.0449.0457.0453.0503.0498.0548.0591.0635.0364.0566.0534.0
EPS13.1013.2713.5113.3714.8814.7116.1917.4518.7711.5114.8714.05
Net margin16.22%16.36%15.98%15.68%17.91%16.83%17.24%17.90%19.22%8.67%11.50%10.73%
PBT margin23.10%22.99%22.95%22.88%24.60%22.47%23.22%23.96%24.64%12.60%14.90%14.80%
Tax rate29.79%28.84%30.34%31.47%27.21%25.11%25.75%25.28%21.99%31.19%22.78%27.54%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 23 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets15,012.014,744.015,061.015,088.014,990.015,515.044,312.044,615.0
Current assets5,314.05,272.05,611.05,879.05,623.06,171.09,392.010,517.0
└ Cash & equivalents508.0538.0835.01,146.0573.0621.01,117.0891.0
└ Other bank balances63.018.04.04.06.084.048.022.0
└ Current investments156.0234.0141.085.0112.089.0866.02,073.0
└ Trade receivables1,944.01,752.01,844.01,783.01,867.02,185.03,031.03,398.0
└ Inventories2,230.02,218.02,279.02,271.02,541.02,467.03,138.03,182.0
Total equity6,198.06,707.06,856.07,504.07,591.08,449.017,585.018,373.0
└ Attributable to owners6,198.06,707.06,856.07,504.07,591.08,449.08,389.018,373.0
└ Non-controlling interest0.00.0——0.0—9,196.00.0
└ Share capital169.0169.0169.0169.0169.0169.0169.0190.0
Borrowings5,297.04,416.03,938.03,048.03,026.02,590.014,798.013,874.0
└ Current2,801.02,306.02,334.01,634.01,834.01,545.03,147.02,254.0
└ Non-current2,496.02,110.01,604.01,414.01,192.01,045.011,651.011,620.0
Trade payables1,679.01,661.02,089.02,188.01,820.01,675.02,358.02,223.0
Current liabilities5,447.04,898.05,426.04,847.04,717.04,435.08,343.07,984.0
Total liabilities8,814.08,037.08,205.07,584.07,399.07,066.026,727.026,242.0
Net debt4,570.03,626.02,958.01,813.02,335.01,796.012,767.010,888.0
Debt / equity0.850.660.570.410.400.310.840.76
Current ratio0.981.081.031.211.191.391.131.32

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow2,368.01,540.03,266.01,683.02,585.01,038.03,023.02,452.0
└ Capex(574.0)(179.0)(433.0)(226.0)(611.0)(196.0)(677.0)(389.0)
Free cash flow1,794.01,361.02,833.01,457.01,974.0842.02,346.02,063.0
Investing cash flow(2,356.0)(166.0)(168.0)(159.0)(540.0)(214.0)(12,713.0)(1,183.0)
Financing cash flow77.0(1,344.0)(2,779.0)(1,215.0)(2,298.0)(826.0)10,151.0(1,505.0)
└ Dividends paid(863.0)(271.0)(1,015.0)(203.0)(1,083.0)(203.0)(1,289.0)(381.0)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash89.030.0327.0311.0(262.0)(2.0)461.0(226.0)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

TORNTPHARM at a glance

  • TORNTPHARM closed at ₹4,689.5 on 20 Nov 2026, +1.70% on the day, +22.4% over one year, 10.7% below its 52-week high of ₹5,250.
  • Delivery was 61.1% of traded quantity on 20 Nov 2026, the 68th percentile of its own 3,629 sessions with a reading (20-session average 61.6%, 1-year average 57.4%).
  • Market capitalisation is ₹1.78 lakh crore at a trailing P/E of 84.0 (trailing EPS ₹55.84).
  • Q2 FY27 results (consolidated, filed 23 Oct 2026): revenue ₹4,979 crore (+50.8% year on year), net profit ₹534 crore (-9.6%); the price moved +0.6% on the first session after.
  • Promoters held 60.78% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 24 Jan 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE685A01028
SeriesEQ
Listed25 Nov 2002
NSE market cap · 17 Nov 2026₹1.78L Cr
Free-float market cap (NSE)₹68,521 Cr
Shares outstanding (NSE)38.04Cr
History from3 Jan 1995
Sessions7,845
Turnover rank#206

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.